Lost in translation? Role of metabolomics in solving translational problems in drug discovery and development

Too few drug discovery projects generate a marketed drug product, often because preclinical studies fail to predict the clinical experience with a drug candidate. Improving the success of preclinical-to-clinical translation is of paramount importance in optimizing the pharmaceutical value chain. Here, we advance the case for a molecular systems approach to crossing the preclinical-to-clinical translational chasm and for metabolomic analysis of readily accessible bodyfluids as a key technology in translational activities.

Section editors:Bart Ellenbroek – Radboud University, Nijmegen, The NetherlandsTwan Ederveen – N.V. Organon, Oss, The Netherlands